Feasibility study of68Ga-labeled CAR T cells for in vivo tracking using micro-positron emission tomography imaging
Feasibility study of68Ga-labeled CAR T cells for in vivo tracking using micro-positron emission tomography imaging
复制标题
DOI:
10.1038/s41401-020-00511-5
复制
发表时间:
2020-09-08
影响因子:
8.2
通讯作者:
Yang, Min
中科院分区:
文献类型:
--
作者:
Wang, Xin-yu;Wang, Yan;Yang, Min
Clinical tracking of chimeric antigen receptor (CAR) T cells in vivo by positron emission tomography (PET) imaging is an area of intense interest. But the long-lived positron emitter-labeled CAR T cells stay in the liver and spleen for days or even weeks. Thus, the excessive absorbed effective dose becomes a major biosafety issue leading it difficult for clinical translation. In this study we used Ga-68, a commercially available short-lived positron emitter, to label CAR T cells for noninvasive cell tracking in vivo. CAR T cells could be tracked in vivo by(68)Ga-PET imaging for at least 6 h. We showed a significant correlation between the distribution of(89)Zr and(68)Ga-labeled CAR T cells in the same tissues (lungs, liver, and spleen). The distribution and homing behavior of CAR T cells at the early period is highly correlated with the long-term fate of CAR T cells in vivo. And the effective absorbed dose of(68)Ga-labeled CAR T cells is only one twenty-fourth of(89)Zr-labeled CAR T cells, which was safe for clinical translation. We conclude the feasibility of(68)Ga instead of(89)Zr directly labeling CAR T cells for noninvasive tracking of the cells in vivo at an early stage based on PET imaging. This method provides a potential solution to the emerging need for safe and practical PET tracer for cell tracking clinically.